Topic Editors

Department of Chemistry, University of Oxford, Oxford, UK
I.P – National Institute for Agrarian and Veterinary Research (INIAV), 4485-665 Vairão, Portugal

Novel Antimicrobial Agents: Discovery, Design and New Therapeutic Strategies, 2nd Volume

Abstract submission deadline
30 September 2023
Manuscript submission deadline
31 December 2023
Viewed by
1246

Topic Information

Dear Colleagues,

We have established one successful Topic on “Novel Antimicrobial Agents: Discovery, Design and New Therapeutic Strategies” with 61 papers, which encouraged us to open a second volume on the same topic. Please see the introduction about the Topic below. The rapid increase in antibiotic resistance raises concerns that we are returning to a pre-antibiotic era, in particular for Gram-negative infections; this is having an increasing impact on an international scale. There are few novel anti-Gram-negative/positive drugs being discovered and entering clinical trials, and therefore, novel drugs along with novel targets, techniques and methods that lead to new drugs are urgently needed. Overcoming resistance to restore the effectiveness of existing drugs or repurposing existing drugs are also important opportunities. This Special Issue is seeking original research articles and synopses (reviews) that demonstrate substantial advances within this field and we are inviting researchers from different fields (e.g., chemistry, biology, biochemistry, pharmacology, medicinal chemistry, PK PD modelers) to contribute to this editorial project. We aim to cover not only traditional but also non-traditional products, with both broad-range and single-target antibiotics for human and animal use.

You are welcome to read the papers published in the first Topic:

Novel Antimicrobial Agents: Discovery, Design and New Therapeutic Strategies

Prof. Dr. Mark G. Moloney
Dr. Sónia Silva
Topic Editors

Keywords

  • antibiotic resistance
  • antimicrobial agents
  • novel anti-Gram-negative drugs
  • novel anti-Gram-positive drugs
  • antibiotics use

Participating Journals

Journal Name Impact Factor CiteScore Launched Year First Decision (median) APC
Antibiotics
antibiotics
5.222 5.5 2012 12.6 Days 2200 CHF Submit
Applied Microbiology
applmicrobiol
- - 2021 12.6 Days 1000 CHF Submit
Chemistry
chemistry
- 2.5 2019 15 Days 1600 CHF Submit
Molecules
molecules
4.927 6.7 1996 13.4 Days 2300 CHF Submit
Tropical Medicine and Infectious Disease
tropicalmed
3.711 4.1 2016 15.1 Days 2000 CHF Submit

Preprints is a platform dedicated to making early versions of research outputs permanently available and citable. MDPI journals allow posting on preprint servers such as Preprints.org prior to publication. For more details about reprints, please visit https://www.preprints.org.

Published Papers (1 paper)

Order results
Result details
Journals
Select all
Export citation of selected articles as:
Article
Phentolamine Significantly Enhances Macrolide Antibiotic Antibacterial Activity against MDR Gram-Negative Bacteria
Antibiotics 2023, 12(4), 760; https://doi.org/10.3390/antibiotics12040760 - 14 Apr 2023
Viewed by 768
Abstract
Objectives: Multidrug-resistant (MDR) Gram-negative bacterial infections have limited treatment options due to the impermeability of the outer membrane. New therapeutic strategies or agents are urgently needed, and combination therapies using existing antibiotics are a potentially effective means to treat these infections. In this [...] Read more.
Objectives: Multidrug-resistant (MDR) Gram-negative bacterial infections have limited treatment options due to the impermeability of the outer membrane. New therapeutic strategies or agents are urgently needed, and combination therapies using existing antibiotics are a potentially effective means to treat these infections. In this study, we examined whether phentolamine can enhance the antibacterial activity of macrolide antibiotics against Gram-negative bacteria and investigated its mechanism of action. Methods: Synergistic effects between phentolamine and macrolide antibiotics were evaluated by checkerboard and time–kill assays and in vivo using a Galleria mellonella infection model. We utilized a combination of biochemical tests (outer membrane permeability, ATP synthesis, ΔpH gradient measurements, and EtBr accumulation assays) with scanning electron microscopy to clarify the mechanism of phentolamine enhancement of macrolide antibacterial activity against Escherichia coli. Results: In vitro tests of phentolamine combined with the macrolide antibiotics erythromycin, clarithromycin, and azithromycin indicated a synergistic action against E. coli test strains. The fractional concentration inhibitory indices (FICI) of 0.375 and 0.5 indicated a synergic effect that was consistent with kinetic time–kill assays. This synergy was also seen for Salmonella typhimurium, Klebsiella pneumoniae, and Actinobacter baumannii but not Pseudomonas aeruginosa. Similarly, a phentolamine/erythromycin combination displayed significant synergistic effects in vivo in the G. mellonella model. Phentolamine added singly to bacterial cells also resulted in direct outer membrane damage and was able to dissipate and uncouple membrane proton motive force from ATP synthesis that, resulted in enhanced cytoplasmic antibiotic accumulation via reduced efflux pump activity. Conclusions: Phentolamine potentiates macrolide antibiotic activity via reducing efflux pump activity and direct damage to the outer membrane leaflet of Gram-negative bacteria both in vitro and in vivo. Full article
Show Figures

Figure 1

Back to TopTop